SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001601830-24-000093
Filing Date
2024-06-27
Accepted
2024-06-27 13:04:08
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 rxrxfinalprospectussupplem.htm 424B5 744000
2 EX-FILING FEES exhibit107-filingfeetable.htm EX-FILING FEES 25741
3 image_1a.jpg GRAPHIC 97233
4 image_2a.jpg GRAPHIC 103228
5 image_3a.jpg GRAPHIC 3967
6 image_4a.jpg GRAPHIC 8429
7 recursionlogohorizontalbla.jpg GRAPHIC 72981
  Complete submission text file 0001601830-24-000093.txt   1165141
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264845 | Film No.: 241077676
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)